15 results
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall
20-F
2021 FY
IINN
Inspira Technologies Oxy B.H.N. Ltd
31 Mar 22
Annual report (foreign)
4:48pm
penalties, and might require us to recall or withdraw a product from the market;
our products may cause or contribute to adverse medical events … harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products, or a recall
POS AM
z8rrsns2
27 Oct 21
Prospectus update (post-effective amendment)
9:17am
424B4
eip9s9iby9r61dw v9ts
15 Jul 21
Prospectus supplement with pricing info
4:06pm
F-1/A
j4w7tep1
1 Jul 21
Registration statement (foreign) (amended)
11:58am
F-1/A
zzawe pudczygh5m9l7
28 Jun 21
Registration statement (foreign) (amended)
11:41am
F-1/A
04ubl5 cw9nx
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
F-1/A
e5m0b ptkcmao6
29 Mar 21
Registration statement (foreign) (amended)
5:19pm
F-1/A
6amsksrt6o2hat
22 Mar 21
Registration statement (foreign) (amended)
11:24am
F-1
idizxw
5 Mar 21
Registration statement (foreign)
3:03pm
DRS/A
r9xgia3e13nl
17 Feb 21
Draft registration statement (amended)
12:00am
DRS
semfpt8
29 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next